Acute cardiac care & resuscitation
Cardiogenic Shock Mortality According to Aetiology in a Mediterranean Cohort: Results from the Shock-CAT Study
Main finding · In-hospital mortalityResult — go to the resultOdds ratio 2.24Authors' conclusion
In our cohort, AMI-CS mortality was increased by two-fold when compared with non-AMI-CS. IABP-SHOCK II score provides better 90 day mortality risk prediction than CardShock score in AMI-CS, but both scores performed similar in non-AMI-CS patients.
Study context
- Population
- Non-selected consecutive cardiogenic shock (CS) patients, Catalonia, December 2018 to November 2019
- Participants
- 382 patients
- Exposure
- Acute myocardial infarction (AMI)-related CS vs non-AMI CS
- AMI-CSn = 232
- non-AMI-CSn = 150reference
- Outcome
- In-hospital mortality
Methodological detailsmulticentre, observational, 8 university hospitals in Catalonia
- Multicentre
- Observational
- 8 university hospitals in Catalonia
Main finding
As reported in the abstract
Odds ratio
2.24
P = 0.019
By group
AMI-CS
37.1
%
non-AMI-CS
26.7%
Observational data: associations, not effects.
Further findings
MCS use
P < 0.001
| Outcome | AUC | P value |
|---|---|---|
| Prediction of 90-day mortality, IABP-SHOCK II vs CardShock score, in AMI-CS | 0.74 vs. 0.66 | P = 0.047 |
| Prediction of 90-day mortality, IABP-SHOCK II vs CardShock score, in non-AMI-CS | 0.64 vs. 0.62 | P = 0.693 |
Original publication
Cardiogenic Shock Mortality According to Aetiology in a Mediterranean Cohort: Results from the Shock-CAT Study. ESC Heart Fail. Published 25 November 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →